StonvexLoading…
StonvexStonvexStonvexCore line items from ACHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.31B | $3.15B | $2.93B | $2.61B |
Operating Income | $-1.07B | $341.88M | $-25.36M | $374.14M |
Net Income | $-1.10B | $255.61M | $-21.67M | $273.14M |
EPS (Diluted) | $-12.16 | $2.78 | $-0.24 | $2.98 |
Total Assets | $5.53B | $5.96B | $5.36B | $4.99B |
Total Liabilities | $3.39B | $2.77B | $2.47B | $2.09B |
Cash & Equivalents | $133.24M | $76.31M | $100.07M | $97.65M |
Free Cash Flow OCF − CapEx | $-439.91M | $-560.69M | $38.21M | $84.42M |
Shares Outstanding | 90.45M | 91.78M | 91.26M | 89.91M |